Novartis AGNVSNYSE
Loading
Total revenue from sales of goods and services
3Y CAGR
+8.0%/yr
vs -1.5%/yr prior
5Y CAGR
+1.9%/yr
Recent acceleration
Acceleration
+9.5pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $54.81B | +6.0% |
| 2024 | $51.72B | +10.8% |
| 2023 | $46.66B | +7.4% |
| 2022 | $43.46B | -1.2% |
| 2021 | $43.97B | -11.9% |
| 2020 | $49.90B | +2.5% |
| 2019 | $48.68B | +5.6% |
| 2018 | $46.10B | +6.2% |
| 2017 | $43.40B | -12.2% |
| 2016 | $49.44B | - |